ARCHIVE SEARCH
      -OR-  
 
  NEWS CHANNELS
Fitness News
 > Asthma Allergy News
Diabetes News
Women's Health News
Men's Health News

  MY NEWS
Personal Archive
My Account

  ABOUT THIS NEWSFEED
About Us
Advertise With Us
Feed Your Site
Contact Us


Site Map
RSS News Feed 

  Website development & hosting
   by Cyber Software Solutions

 
Under-the-Tongue Tablet Approved for Grass Allergies
To be started 4 months before allergy season

WEDNESDAY, April 2, 2014 (HealthDay News) -- Oralair has been approved by the U.S. Food and Drug Administration as the first under-the-tongue treatment for certain grass allergies.

The tablet contains freeze-dried pollen extracts of five grasses: Kentucky Blue Grass, Orchard, Perennial Rye, Sweet Vernal and Timothy. The once-daily tablet is placed under the tongue where it rapidly dissolves, the agency said in a news release.

Sanctioned for people aged 10 to 65, Oralair is designed to be started four months before the allergy season begins. The first dose should be given at a doctor's office, where the user can be observed for any serious reactions. After that, the product can be taken at home, the FDA said.

Some 30 million people in the United States and 500 million globally have been diagnosed with allergic rhinitis, the medical term for nasal allergies or hay fever. Common symptoms include sneezing, itchy and runny nose, nasal congestion, and itchy and watery eyes.

Oralair's safety and effectiveness were clinically evaluated in some 2,500 people. Those who took Oralair had up to 30 percent fewer allergy symptoms than those who took a placebo, the FDA said.

The product's label will include a boxed warning that people who are highly allergic to grass pollen may have a severe reaction, including life-threatening anaphylaxis. More common side effects reported were itchy ears and mouth, swelling of the mouth and throat irritation.

Oralair is produced by the French firm Stallergenes S.A.

More information

Medline Plus has more about allergies.



-- Scott Roberts

Copyright © 2014 HealthDay. All rights reserved.


Back to Top Stories
  GOOGLE ADS